Recent important trials of pharmacotherapy in Parkinson’s disease

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.6, Iss.6, 2005-06, pp. : 1025-1028

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rasagiline in the pharmacotherapy of Parkinson’s disease – a review

By Rascol Olivier

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 12, 2005-10 ,pp. : 2061-2075

Informa Healthcare

Access to resources Recommend Favorite

Recent developments in the pharmacological treatment of Parkinson’s disease

By Tuite Paul Riss Jennifer

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 8, 2003-08 ,pp. : 1335-1352

Informa Healthcare

Access to resources Recommend Favorite

Parkinson’s Disease: Recent Updates in the Identification of Human Dopa Decarboxylase Inhibitors

Current Drug Metabolism, Vol. 17, Iss. 5, 2016-06 ,pp. : 513-518

Bentham Science Publishers

Access to resources Recommend Favorite

Parkinson's disease: emerging pharmacotherapy

By Strecker Karl Schwarz Johannes

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 4, 2008-12 ,pp. : 573-591

Informa Healthcare

Access to resources Recommend Favorite

Entacapone in the management of Parkinson’s disease

By Waters Cheryl Henchcliffe Claire

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 7, 2002-07 ,pp. : 957-963

Informa Healthcare

Access to resources Recommend Favorite